PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway
Aging · 2023
DOI: 10.18632/aging.205152 ↗At a glance
Journal article in Aging, 2023. Written by Jiacheng Zhong and 9 co-authors. Institution: Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Major MEDLINE topics: Prostatic Neoplasms, Proto-Oncogene Proteins c-akt. Cited 3 times so far (Crossref); 48 references. The full text is freely available in PubMed Central.
Abstract (original language)
Protein L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1) is a repair enzyme that catalyzes the conversion of isomerized aspartic acid (iso-Asp) residues into their normal structure, thereby restoring the configuration and function of proteins. Studies have shown that PCMT1 is overexpressed in several tumors and affects patients' prognosis. However, there are few reports on the role of PCMT1 in prostate cancer (PCa). In the present research, with the assistance of The Cancer Genome Atlas Program (TCGA) database, we found that PCMT1 was overexpressed in PCa tissues. The results of quantitative reverse transcription-polymerase chain reaction (qRT-PCR), western blot and immunohistochemistry staining also showed that PCMT1 expression was significantly increased in PCa tissues and cell lines. In PCa clinical samples, PCMT1 expression was closely related to Gleason score, clinical stage, lymph node metastasis and bone metastasis. The experiments of overexpression and knockdown of PCMT1 in vitro or in vivo showed that PCMT1 can significantly promote the proliferation, migration and invasion of PCa cells, inhibit cell apoptosis, and promote the growth of PCa. We furthermore confirmed that PCMT1 regulated the migration, invasion and apoptosis of PCa cells by modulating the phosphatidylinositol 3-kinase/AKT kinase/glycogen-synthase kinase-3β (PI3K/AKT/GSK-3β) signaling pathway. Collectively, PCMT1 plays a cancer-facilitative role in PCa by promoting the proliferation, migration and invasion of PCa cells, and inhibiting apoptosis. Therefore, PCMT1 is considered to represent a novel target for treating PCa.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Urology, Jingzhou Central Hospital, Jingzhou 434020, China.
- Department of Emergency, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.
- Department of Urology, The First People’s Hospital of Shangqiu City, Shangqiu 476100, China.
- Department of Urology, Qianjiang Central Hospital, Qianjiang 433100, China.
Cite
APA
Zhong, J., Yuan, C., Liu, L., Du, Y., Hui, Y., Chen, Z., Diao, C., Yang, R., Liu, G., & Liu, X. (2023). PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway. Aging. https://doi.org/10.18632/aging.205152
Vancouver
Zhong J, Yuan C, Liu L, Du Y, Hui Y, Chen Z, et al. PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway. Aging. 2023. doi:10.18632/aging.205152
BibTeX
@article{Zhong2023,
author = {Zhong, Jiacheng and Yuan, Chao and Liu, Lin and Du, Yang and Hui, Yumin and Chen, Zhiyuan and Diao, Changhui and Yang, Rui and Liu, Guiyong and Liu, Xiuheng},
title = {PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205152}
}
EUVIMED